Welcome to our dedicated page for Tilt Hldgs news (Ticker: TLLTF), a resource for investors and traders seeking the latest updates and insights on Tilt Hldgs stock.
TILT Holdings Inc. (TLLTF) generates a wide range of company news tied to its role as a global provider of cannabis business solutions. Its disclosures describe a portfolio that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, with a core focus on Jupiter Research LLC, a wholly owned subsidiary active in vaporization hardware design, research, development, manufacturing and distribution. News about TILT often highlights how these activities support cannabis brands and retailers across North America, South America, Israel and the European Union.
Recent announcements show that TILT’s news flow covers both operational performance and strategic restructuring. Earnings releases discuss quarterly financial and operating results, including revenue trends, gross margin dynamics and the impact of strategic shifts such as divesting plant-touching assets in Massachusetts and Ohio or transitioning parts of Jupiter’s business to a commission-based model. Operational updates also describe regulatory approvals, such as European Union medical device certification for a handheld liquid inhalation device developed by Jupiter, and agreements with partners like Curaleaf International for commercialization in medical markets.
Another important stream of news relates to capital structure and creditor arrangements. TILT has reported entering into secured note purchase agreements for bridge financing, receiving default notices from landlords on certain cultivation properties, and negotiating forbearance arrangements. The company has also issued multiple releases about its CCAA restructuring process in the Supreme Court of British Columbia, including the initial order granting creditor protection, the proposed plan of arrangement to take the company private, and notices of meetings for noteholders.
For users following TLLTF on this news page, the coverage provides a consolidated view of TILT’s financial results, restructuring milestones, asset sales, regulatory certifications and governance events such as shareholder meeting outcomes. Investors and observers can use this archive to trace how TILT’s strategy has evolved toward Jupiter-centered, asset-light operations and to understand the context behind its delisting and restructuring decisions.
TILT Holdings announces participation in two investor conferences in December 2021. The Cowen’s 4th Annual Cannabis Conference will take place virtually from November 29 to December 1, with TILT's management available for one-on-one meetings on December 1. The Benzinga’s Global Small Cap Conference is scheduled for December 8-9, where CEO Gary Santo will present on December 9 at 10:50 AM ET and join a panel at 12:35 PM ET. TILT provides cannabis business solutions across multiple regions, aiming to enhance brand presence in the cannabis market.
TILT Holdings has received final adult-use licenses for its Taunton facility from the Massachusetts Cannabis Control Commission. This approval allows retail and wholesale sales of adult-use cannabis to begin upon final inspection. The Taunton location features a 100,000 sq. ft. cultivation and processing facility and a dispensary that serves over 8,000 patients in the Boston area. CEO Gary Santo emphasized that this marks a pivotal moment for TILT, promising growth and enhanced market visibility.
TILT Holdings announces approval from the Massachusetts Cannabis Control Commission for its subsidiary, Commonwealth Alternative Care, to begin adult-use retail operations at the Brockton dispensary starting November 22, 2021. The Brockton location, which previously serviced medical patients, will celebrate its grand opening on December 4, 2021. This event will feature vendor pop-ups and local food trucks. TILT aims to expand cannabis access in Massachusetts, highlighting the growing demand in the greater Boston area.
TILT Holdings Inc. reported its Q3 2021 financial results, revealing a 37% increase in revenue to $53.4 million. Cannabis and inhalation revenue grew by 19% and 42%, respectively. Despite higher freight costs impacting gross margins, TILT maintains its 2021 revenue guidance of $205-$210 million, expecting to meet the lower end of this range. Adjusted EBITDA for the year is projected between $24-$26 million, up 42%-54% from 2020. Operating expenses improved to 30.5% of revenue. TILT also made significant partnerships to expand its market reach.
TILT Holdings has expanded its partnership with Airo Brands to include production and distribution in Massachusetts, in addition to Pennsylvania. This follows a successful collaboration since 2016, enhancing TILT's portfolio in the cannabis inhalation market. Airo, a leading brand with products in over 1,250 dispensaries across the U.S. and Puerto Rico, will have its popular products distributed by TILT's Commonwealth Alternative Care. Executives from both companies expressed optimism about this partnership's impact on market share and brand visibility.
TILT Holdings, a cannabis solutions provider, will host a conference call on November 15, 2021, at 5:00 p.m. ET to discuss its Q3 financial results for the period ending September 30, 2021. The results will be released in a press release prior to the call. Interested parties can join by dialing in or through a webcast available on the company's investor relations website. TILT operates across multiple states and internationally, providing a range of services, including technology and brand development for cannabis businesses.
TILT Holdings Inc. has completed the sale of its wholly-owned subsidiary, Sante Veritas Therapeutics, to Meridian 125W Cultivation Ltd. for approximately C$900,000, with part of the proceeds aimed at settling outstanding liabilities. This divestment aligns with TILT's strategy to focus on core operations and high-growth markets in the U.S. CEO Gary Santo emphasized that the sale marks the conclusion of non-core asset sales, allowing the company to concentrate on future growth.
Summary not available.
TILT Holdings (OTCQX: TLLTF) and Greenlane Holdings (NASDAQ: GNLN) are supporting Smoore Technology in its complaint against patent infringements by various vape products. The complaint, filed with the U.S. International Trade Commission, aims to block the import of these infringing products. Smoore Technology, a leader in vaporization technology, emphasizes the importance of protecting its CCELL brand's quality and integrity. This action reflects a commitment to consumer safety and aims to eliminate lower-quality and potentially harmful products from the market.
TILT Holdings Inc. has announced the opening of its Commonwealth Alternative Care dispensary in Brockton, Massachusetts, with doors opening on October 1, 2021. The Massachusetts Cannabis Control Commission has approved the dispensary for medical marijuana sales, and it is slated for a grand opening celebration on October 16, 2021. Operating hours will be from 10 a.m. to 6 p.m., seven days a week. TILT anticipates the approval for adult-use sales will follow shortly after final inspections.